Datamonitor
Charles House
119 Farringdon Road
London
NW3 5JJ
United Kingdom
Tel: 44-20-7675-7000
Fax: 44-20-7675-7500
Website: http://www.datamonitorhealthcare.com
About Datamonitor
Bringing you closer to the pharma market…Datamonitor Healthcare provides expert independent analysis of key diseases, drugs and companies, in addition to epidemiological research and strategic insights. Our state-of-the-art service features cutting-edge interactivity to help you visualize data and identify trends faster.
34 articles about Datamonitor
-
Datamonitor Release: Federal Trade Commission Vs. Federal Trade Commission - Visualize the "Pay for Delay" Impact (Infographic)
7/9/2013
-
Datamonitor Release: AMNOG May Cause Havoc in German Diabetes Market - Analyst Opinion
7/9/2013
-
Datamonitor Report: Battle against MRSA to Net Pharma Industry $2 Billion
3/9/2011
-
Datamonitor Report: Merck Serono's Future MS Market Foothold Loosens
2/18/2011
-
Datamonitor Report: Price is Right for Sanofi-Aventis (France) – Analyst Comment
2/16/2011
-
Datamonitor Report: Breast Cancer Cases on the Rise, Except in US
2/14/2011
-
Datamonitor Report: Diabetes Pipeline Cannot Reverse Cardiovascular and Metabolic Market Decline
2/10/2011
-
Datamonitor Report: $156 Million Licensing Deal to Broaden Fidaxomicin's Reach
2/9/2011
-
Datamonitor Report: Can India Become a Biosimilar Powerhouse?
2/7/2011
-
Datamonitor Report: Good and Bad News for Major MS Players
1/21/2011
-
Datamonitor Report: Rapidly Deteriorating Growth for Pharma
1/20/2011
-
Datamonitor Report: US Most Susceptible to Brand Erosion Post Patent Expiry
1/12/2011
-
Datamonitor Report: Is the Decade Long Flirtation with Vaccines Over?
11/23/2010
-
Datamonitor Report: Market Development Key for Testosterone Replacement Therapy
11/16/2010
-
Datamonitor Report: Challenging Year for Roche but Restructuring Will Help Maintain Strong Fiscal Position
11/16/2010
-
Datamonitor Report: Can Pfizer Inc. Rescue Hormonal Replacement Therapy?
11/8/2010
-
Datamonitor Report: Uncertainty for US Healthcare Reform?
11/3/2010
-
Datamonitor Report: Analyst Comments on AstraZeneca PLC and Sanofi-Aventis (France) Q3 Results
10/28/2010
-
Datamonitor Report: National Health Service Faces a Funding Shortfall of £42 Billion and Expert Comment on CSR Impacts to Healthcare and Pharma
10/21/2010
-
Datamonitor Report: Growth Opportunity in Brazil, But No Easy Pickings
9/22/2010